Skip to main content
. 2020 Nov 30;8(12):555. doi: 10.3390/biomedicines8120555
mCRPC Metastatic castration resistan prostate cancer
PET/CT Positron emission computed tomography
TLA Total lesion glycolysis
MATV Metabolically active tumor volume